期刊文献+

拟诊肺癌而行全肺切除的良性病变

Pulmonary Benign Disease Misdiagnosed as Lung Cancer Treated with Pneumonectomy
原文传递
导出
摘要 [目的]探讨肺内良性病变诊为肺癌而行全肺切除的原因。[方法]回顾性分析1998年8月~2008年8月因拟诊肺癌而行全肺切除的良性疾病患者14例的临床资料。[结果]14例患者术前均拟诊为肺癌,行左全肺切除术11例,右全肺切除3例。术后病理为肺结核8例(3例伴淋巴结结核),肺脓肿2例,炎性假瘤2例,炎性肉芽肿1例,错构瘤1例。术后3例出现并发症(肺动脉栓塞2例,ARDS1例),并发症发生率为21.4%,无围手术期死亡发生。[结论]肺结核、炎性肉芽肿、肺脓肿、炎性假瘤、错构瘤是最易诊为肺癌而行全肺切除的良性疾病,应严格把握肺内良性病变行全肺切除的手术指征。 [Purpose] To explore the cause of pulmonary benign disease misdiagnosed as lung cancer treated with pneumoneetomy. [Methods] The clinical data of 14 cases with pulmonary benign diseases misdiagnosed as lung cancer treated with pneumonectomy from Aug. 1998 to Aug. 2008 were analyzed retrospectively. [Results] Of the 14 Cases, 11 cases underwent left pneumonectomy; 3 cases, fight pneumonectomy. Postoperative pathological revealed 8 cases with pulmonary tuberculosis (3 cases with lymph node tuberculosis), 2 cases with lung abscess, 2 cases with inflammatory pseudotumor of lung, 1 case with inflammatory granuloma and 1 case with hamartoma. Postoperative complication was found in 3 cases (21.4%) including 2 cases with pulmonary embolism and 1 ARDS. No death occurred perioperation. [Conclusion] The most common benign diseases misdiagnosed as lung cancer undergoing pneumoneetomy are pulmonary tuberculosis, hamartoma, inflammatory pseudotumor, lung abscess, inflammatory granuloma and hamartoma. More attention should be paid to surgical indication for total pneumonectomy with pulmonary benign diseases.
出处 《肿瘤学杂志》 CAS 2009年第6期512-514,共3页 Journal of Chinese Oncology
关键词 良性病变 肺肿瘤 全肺切除术 鉴别诊断 pulmonary benign diseases lung neoplasm pneumonectomy diagnose, differential
  • 相关文献

参考文献10

二级参考文献54

  • 1周志有,夏银献,常春林.肺部炎性假瘤手术治疗45例临床体会[J].中国医师杂志,2003,5(S1):163-164. 被引量:3
  • 2谢茶生.肺结核与肺癌的相互误诊[J].湖南医学,1993,10(3):189-189. 被引量:7
  • 3高禹舜,张德超,赫捷,孙克林,张大为,张汝刚.Ⅰ期非小细胞肺癌的诊断与外科治疗[J].中华肿瘤杂志,2005,27(1):52-55. 被引量:16
  • 4李冀文 王玉珍 等.纤维支气管镜对成人胸内结核性淋巴结病的诊断[J].中华结核和呼吸杂志,1991,9(6):358-359.
  • 5Poleri C, Morevo JL, Nieva B, et al. Risk of recurrence in palients with surgically resected stage Ⅰ non-small cell lung carcinoma: histopathologic and immunohistochemical analysis. Chest, 2003, 123 : 1858-1867.
  • 6Mountain CF. Revisions in the International System for Slaging Lung Cancer. Chest, 1997, 111:1710-1717.
  • 7Collins LG, Haines C, Perkel R, et al. Lung cancer: diagnosis and management. Am Faro Physician, 2007, 75:56-63.
  • 8DouiUant JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin remus observation in patients with completely resected stage Ⅰ B-Ⅲ A non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ ANITA ]): a randomised controlled trial. Lancet Oncol, 2006, 7:719-727.
  • 9Gabor S, Renner H, Popper H, et al. Invasion of blood vessel as significant prognostic factor in radically resected T1-3N0M0 nonsmall-cell lung cancer. Eur J Cardiothorac Surg, 2004, 25:439- 442.
  • 10Ichinose Y, Yano T, Asoh H, et al. Prognostic factors obtained by a pathologic examination in completely resected non-small cell lung cancer: an analysis in each pathologic stage. J Thorac Cardiovasc Stag, 1995, 110:601-605.

共引文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部